Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. [electronic resource]
Producer: 20190423Description: 632-637 p. digitalISSN:- 1532-866X
- Adalimumab -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Antirheumatic Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Certolizumab Pegol -- therapeutic use
- Enthesopathy -- drug therapy
- Etanercept -- therapeutic use
- Female
- Humans
- Infliximab -- therapeutic use
- Male
- Middle Aged
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Ustekinumab -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.